IBRX Next Earnings Date Notes

— ImmunityBio (IBRX) is a clinical-stage biotechnology company focused on developing next-generation immunotherapies that harness both the innate & adaptive arms of the immune system to treat cancer & infectious diseases. Their pipeline centers on platforms such as their Natural Killer (NK) cell therapies, monoclonal antibodies, & IL-15 superagonist (Anktiva, or N-803), with a lead indication in non-muscle invasive bladder cancer (NMIBC). For investors, the most relevant business metrics to follow include: clinical trial milestones & data, particularly for Anktiva's pivotal studies; regulatory updates, such as FDA decisions related to their Biologics License Application; partnership or commercialization developments; cash runway & quarterly burn rate; as well as manufacturing & distribution capability scale-up. Pay close attention to any details on regulatory timelines, enrollment in ongoing studies, revenue (if any is reported), & updates on how the company is navigating manufacturing or supply chain hurdles. Listening to the earnings call, it's beneficial to note management's commentary on planned product launches, partnership opportunities, & how they plan to secure additional funding to support their ambitious R&D efforts. The next projected earnings date for IBRX is 8/4/2026 7:00 am (stay tuned for a confirmed earnings date once announced).

IBRX Next Earnings Date FAQ

On this page we presented the IBRX Next Earnings Date information for ImmunityBio along with recent past earnings dates. For Q1 of 2026, IBRX reported earnings of -0.080/share, with the earnings report taking place on 5/7/2026. For Q4 of 2025, IBRX reported earnings of -0.060/share, with the earnings report taking place on 2/23/2026. For Q3 of 2025, IBRX reported earnings of -0.070/share, with the earnings report taking place on 11/4/2025. For Q2 of 2025, IBRX reported earnings of -0.100/share, with the earnings report taking place on 8/5/2025. For Q1 of 2025, IBRX reported earnings of -0.150/share, with the earnings report taking place on 5/12/2025. Based on these past earnings dates, the projected next earnings date for IBRX is 8/4/2026 7:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as ImmunityBio. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to ImmunityBio shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research ImmunityBio next earnings dates as well as any other stock out there in our coverage universe, to see when the next IBRX earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up IBRX's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the IBRX next earnings date.